Medtronic Inc (MDT) 78.01 $MDT
Look for Shares of Medtronic to Potentially Pullback after Yesterday's 1.21% Rise
Comtex SmarTrend(R) - Wed Apr 22, 4:22PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 78.01 (+0.93)
After Yesterday's Rally of 1.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Apr 22, 4:21PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 78.01 (+0.93)
Inspire Therapy Approved for Sleep Apnea Patients at Military and VA Hospitals
PR Newswire - Wed Apr 22, 10:46AM CDT
Inspire Medical Systems, Inc., announced today that Inspire® Upper Airway Stimulation (UAS) therapy has been approved for inclusion in the Government Services Administration (GSA) Federal Supply Schedule (FSS). The agreement enables access to Inspire therapy to patients cared for at Veteran Administration hospitals, military treatment facilities, and Indian Health Services hospitals. Inspire therapy is an FDA approved implantable device for the treatment of Obstructive Sleep Apnea (OSA), a common condition affecting 18 million Americans.
MDT: 78.01 (+0.93)
North American Nerve Repair & Regeneration Market by Type, by Procedure - Forecast to 2019
M2 - Wed Apr 22, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hs9468/north_american) has announced the addition of the "North American Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) -Forecast to 2019" report to their offering. The North American nerve repair and regeneration market was valued at $1,671.4 million in 2014. It is projected to reach $2,873.0 million by 2019, at a CAGR of 11.4% during the forecast period. The market, by type, is segmented into nerve repair by neurostimulation (held largest share in 2014) and nerve repair by biomaterials. In North America, the U.S. is a key region the for nerve repair and regeneration market. Nerve repair and regeneration deals with healing damaged nerves and restoring any functioning of body parts lost due to nerve damage. This is one of the more challenging of neurological procedures. The growth of nerve repair and regeneration market has been rapid in all countries, mainly due to the constantly rising surgeries pertaining to nerves and the high incidence of chronic neurological disorders like epilepsy, Parkinson's, and Alzheimer's diseases. The increase in neurological surgeries drives the need for products such as nerve conduits, wraps, protectors, and connectors; thus, it is a driver of market growth. The North American nerve repair and regeneration market constitutes 32.8% of the global nerve repair and regeneration. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Product 6 Nerve Repair and Regeneration Market, By Country 7 Nerve Repair and Regeneration Market: Competitive Landscape 8 Nerve Repair and Regeneration Market: Company Profiles - Axogen, Inc. - Integra Lifesciences Corporation - Medtronic, Plc. - Polyganics - St. Jude Medical - Stryker For more information visit http://www.researchandmarkets.com/research/hs...h_american
MDT: 78.01 (+0.93), STJ: 73.55 (+4.43)
Medtronic DBS systems cleared for full-body MRI in Europe
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 9:38AM CDT
MDT: 78.01 (+0.93)
Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) - Forecast to 2019
M2 - Wed Apr 22, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2c5p7/asian_internal) has announced the addition of the "Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019" report to their offering. The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019 Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market. In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Asia-Pacific Internal Neuromodulation/Neurostimulation Market: Macro Indicators, By Geography, 2014 ($ Bn) 4 Executive Summary 5 Market Overview 6 Internal Neurostimulation/Neuromodulation Market, By Modality 7 Internal Neurostimulation/Neuromodulation Market, By Application 8 Internal Neurostimulation/Neuromodulation Market, By Geography 9 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape 10 Internal Neurostimulation/ Neuromodulation Market, By Company - Boston Scientific Corporation (U.S.) - Cerbomed Gmbh (Germany) - Cyberonics, Inc. (U.S.) - Depuy Synthes Companies (U.S.) - Enteromedics, Inc. (U.S.) - Medtronic, Inc. (U.S.) - St. Jude Medical (U.S.) - Synapse Biomedical, Inc. (U.S.) - Uroplasty, Inc. (U.S.) For more information visit http://www.researchandmarkets.com/research/c2...n_internal
BSX: 18.41 (+0.10), MDT: 78.01 (+0.93), STJ: 73.55 (+4.43), UPI: 1.22 (-0.03), CYBX: 63.59 (+0.27)
Health Care Equipment and Supplies Equities Technical Data - Medtronic, ResMed, Unilife, Edwards Lifesciences, and InspireMD
PR Newswire - Wed Apr 22, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
UNIS: 3.79 (-0.12), MDT: 78.01 (+0.93), RMD: 73.28 (+0.17), EW: 140.87 (+0.39), NSPR: 0.26 (+0.02)
3 Things to Know About Apple and IBM's Most Recent Cloud Computing Innovation
Andrew Tonner, The Motley Fool - Motley Fool - Tue Apr 21, 1:03PM CDT
IBM's and Apple's CEOs. Image source: IBM Beyond plenty of publicity, just what have Apple and IBM gained from the much-ballyhooed partnership they announced last July? Well, since then, Apple and IBM have introduced 23 enterprise-focused...
JNJ: 100.43 (+0.13), MDT: 78.01 (+0.93), IBM: 165.36 (+1.10), AAPL: 128.62 (+1.71)
Medtronic Begins Enrollment in Feasibility Study of Valiant 'Mona LSA' Branch Thoracic Stent Graft System
M2 - Tue Apr 21, 11:26AM CDT
Medtronic plc (NYSE: MDT) today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery (LSA).
MDT: 78.01 (+0.93)
Asian Nerve Repair & Regeneration Market by Type, by Procedure - Analysis and Forecast to 2019
M2 - Tue Apr 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/54h2rs/asian_nerve) has announced the addition of the "Asian Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Analysis and Forecast to 2019" report to their offering. The Asian nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which Nerve repair by Neurostimulation holds the highest market share of 57%, followed by nerve repair by biomaterials with a market share of 43% . The Asian Nerve repair and regeneration market is projected to grow at a CAGR of 11.7% by 2019, which is driven by several factors such as technological advancements and an increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market. In the Asian region, the maximum market share is held by Japan and China, due to the increasing diseases related to nerves such as Parkinson's and Epilepsy, as these are the major application areas for the devices , along with an increase in the population. All the same, nerve repair by neurostimulation is also widely used. The report focuses on in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas. Technological advancements have been a major driving factor of the market, which has been deeply analysed and put through the reports. Due to this increasing demand, the government has also shown its support; however, certain stringent rules and regulations such as the implementation of taxes may hamper the growth of the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Type 6 Nerve Repair and Regeneration Market, By Geography 7 Nerve Repair and Regeneration : Competitive Landscape 8 Nerve Repair and Regeneration Market, By Company - Axogen, Inc. - Integra Lifesciences Holdings Corp. - Medtronic, Inc. - Polyganics - S.T Jude Medical - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/54...sian_nerve
MDT: 78.01 (+0.93), SYK: 96.45 (+1.74)
Insulin Infusion Pumps: World Market Analysis 2015-2019
M2 - Tue Apr 21, 4:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r6qfb4/insulin_infusion) has announced the addition of the "Insulin Infusion Pumps: World Market Analysis" report to their offering. Infusion pumps are used to infuse necessary fluids, including medications and/or nutrients, to a patient's circulatory system. Insulin infusion pumps are considered specialty medical infusion pumps, ambulatory electromechanical pumps typically used to deliver insulin to patients with diabetes. They provide precise insulin delivery and lifestyle flexibility for people with diabetes by delivering small amounts of insulin continuously (24/7) to ensure normal function of the body. Insulin Infusion Pumps: World Market Analysis analyzes the current and potential world market for insulin infusion pumps, with market forecasts to 2019. The report includes discussion of: - Key Insulin Pump Products, Manufacturers, and Recent Developments - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Safety Issues - Advances in the Market The profiled companies include: - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INSULIN INFUSION PUMPS - Brief History of the Infusion Pump Industry - Diabetes Statistics, United States and Europe - Insulin Infusion Pumps - Continuous Glucose Monitoring Systems - Key Insulin Pump Products, Manufacturers, and Recent Developments - Animas Corporation - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care, Inc. - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Manufacturer Profiles - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development Co., Ltd - Tandem Diabetes Care, Inc. - Safety Issues - Advances in the Market For more information visit http://www.researchandmarkets.com/research/r6...n_infusion
JNJ: 100.43 (+0.13), PODD: 30.79 (-0.20), MDT: 78.01 (+0.93)
3 Stocks Driving The Health Care Sector Higher
at The Street - Mon Apr 20, 12:24PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
MDT: 78.01 (+0.93), UNH: 117.81 (-1.47), AMGN: 169.10 (+0.64)
IBM Employs Watson Capabilities Into Healthcare Analytics
Lior Ronen - at Seeking Alpha - Mon Apr 20, 11:25AM CDT
JNJ: 100.43 (+0.13), MCK: 231.27 (-0.02), MDT: 78.01 (+0.93), IBM: 165.36 (+1.10), AAPL: 128.62 (+1.71), CERN: 72.41 (+0.19)
Study of Upper Airway Stimulation (UAS) Therapy for Sleep Apnea Named a Top Ten Outstanding Research Paper
PR Newswire - Mon Apr 20, 11:00AM CDT
Inspire Medical Systems, Inc., announced today that a scientific paper on its Inspire Upper Airway Stimulation (UAS) therapy for obstructive sleep apnea (OSA), has been recognized with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. The awards were announced at the Forum's Annual Meeting in Washington, D.C. The 10 winning papers were chosen based on their degree of innovation from a pool of more than 50 nominations from 30 research and academic health centers nationwide.
MDT: 78.01 (+0.93)
MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks"
M2 - Mon Apr 20, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgkmfx/medintellibase) has announced the addition of the "MedIntelliBase? Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks" " subscription to their offering. Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage. MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require. In particular, MedIntelliBase (MIB) MarketTracks are concise Summaries of Clinical Trials and Product Technologies. All Clinical Trial Summaries are indexed by Company, Principal Investigator (PI) and PI Study Site. All Product Technology Summaries are indexed by Company. The Summaries are updated throughout the month published in final form each month with Summary Update Emails sent to you and RSS Breaking News fed to you. For the Subject Area ""Lower Limb ""Critical Limb Ischemia (CLI) Therapeutics - MarketTracks: As of January 2015 the Number of Clinical Trials/Registries included = 45; the Number of Product Technologies included = 25; the Number of Companies included = 22. This Subject Area is growing as its authors discover newly announced trials and emerging product technologies. Key Topics Covered: 1. Arteries 2. Therapeutic Approach 3. Clinical Focus 4. Companies Companies Mentioned - Abbott Vascular Devices - AtheroMed, Inc. - Bard Peripheral Vascular, Inc. / C. R. Bard - BIOTRONIK - Boston Scientific Corporation, Inc. - Cardiovascular Systems, Inc. - Cook, Inc. - Covidien (eV3) - CryoVascular Systems, Inc. (Boston Scientific Corporation) - Edwards Lifesciences - EKOS Corporation - Guidant Corporation (Abbott Vascular Devices/Boston Scientific Corporation) - Intact Vascular, Inc. - Invatec (Medtronic) - Lutonix, Inc. - Medtronic (Bayer / MEDRAD Interventional (Possis Medical, Inc.)) - Medtronic Vascular - Spectranetics Corporation - TriReme Medical - Terumo Medical Corporation - Vascular Solutions, Inc. For more information visit http://www.researchandmarkets.com/research/fg...ntellibase
BSX: 18.41 (+0.10), SPNC: 34.65 (-0.07), MDT: 78.01 (+0.93), CSII: 39.07 (+0.01), EW: 140.87 (+0.39), VASC: 33.30 (+4.06)
MedIntelliBase Lower Limb Advanced Arterial Therapeutics Alerts ("LLA[A] Rx Alerts"
M2 - Mon Apr 20, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/48j45j/medintellibase) has announced the addition of the "MedIntelliBase? Lower Limb Advanced Arterial Therapeutics Alerts ("LLA[A] Rx Alerts" " subscription to their offering. MedIntelliBase? Alerts Subject Area - Lower Limb Advanced Arterial Therapeutics Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage. In particular, MedIntelliBase Alerts services instantly gives you the intelligence you need - whenever and wherever you are MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require. MedIntelliBase Alerts precisely targets clinical research abstracts and news for you - tracking, filtering, emailing, streaming, pushing via apps and archiving (keyword searchable) critical technology, regulatory and market developments using keywords you specify in your industry segment. This Subject Area is growing as its authors discover news and abstracts about newly emerging product technologies; medical advancements; new competitors; regulatory, legal and commercial activity. Key Topics Covered: 1. Arteries 2. Therapeutic Approach 3. Clinical Focus 4. General PAD Literature 5. Aachen Resonance 6. Abbott Vascular (Guidant Corporation) 7. AngioScore 8. Angioslide 9. Atrium Medical 10. Avinger 11. B. Braun Vascular 12. Bard 13. BIOTRONIK 14. Boston Scientific Corporation 15. Blue Medical 16. Cardionovum 17. Cardiovascular Systems Inc. 18. Cook Medical 19. Cordis 20. Covidien (eV3 / Fox Hollow) 21. Edwards Lifescience 22. EuroCor 23. Hansen Medical 24. Medtronic Vascular (Invatec) 25. NovoStent Corporation 26. Spectranetics 27. Terumo Medical 28. TriReme Medical 29. W. L. Gore For more information visit http://www.researchandmarkets.com/research/48...ntellibase
BSX: 18.41 (+0.10), SPNC: 34.65 (-0.07), MDT: 78.01 (+0.93), CSII: 39.07 (+0.01), HNSN: 0.90 (-0.01)
Global Defibrillators Market 2015-2019 - Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)
M2 - Mon Apr 20, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4vpdf/defibrillators) has announced the addition of the "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019" report to their offering. The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Factors such as development of technologically advanced defibrillator, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillator, and increasing number of training and awareness programs across the globe are propelling the growth of the market. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In addition to this, the increasing pricing pressure on market players and frequent product recalls are the key challenges faced by market players in the market. On the basis of regions, this market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2014, North America is expected to dominate the global defibrillators market. Growth of this region can be attributed to the technological advancements and product innovations, increasing number of public defibrillation programs, rising prevalence of obesity, and rising focus of key players to expand their business in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019, due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Defibrillators Market, By Product 8 Global Defibrillators Market, By End User 9 Defibrillator Market, By Region 10 Competitive Landscape 11 Company Profiles - Biotronik Se & Co.KG - Boston Scientific Corporation - Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited) - Heartsine Technologies, Inc. - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare (A Division of Koninklijke Philips N.V.) - Physio-Control, Inc. - ST. Jude Medical, Inc. - Sorin Group - Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) For more information visit http://www.researchandmarkets.com/research/w4...brillators
BSX: 18.41 (+0.10), MDT: 78.01 (+0.93), STJ: 73.55 (+4.43)
Pain-Free Blood Tests? Sign Me Up!
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 19, 8:19AM CDT
Source: National Cancer Institute, Facebook. One of the primary tenets of the Patient Protection and Affordable Care Act, known affably as Obamacare, is to lower the uninsured rate and open avenues for consumers to get proper preventative care....
MDT: 78.01 (+0.93), EXAS: 22.28 (+0.24), MNKD: 4.90 (-0.09)
3 Megatrends in Healthcare
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 19, 6:14AM CDT
Source: AstraZeneca. For investors, the healthcare sector is where dreams can be made many times over -- or potentially lost in a flash. Although all sectors look to the horizon and think about "what might be," no sector is more reliant on the...
ANTM: 152.84 (-0.04), MYGN: 33.74 (+0.28), MDT: 78.01 (+0.93), PFE: 34.93 (+0.04), CERN: 72.41 (+0.19), NVS: 103.45 (-0.62)
Look for Shares of Medtronic to Potentially Pullback after Yesterday's 1.21% Rise
Comtex SmarTrend(R) - Wed Apr 22, 4:22PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 78.01 (+0.93)
After Yesterday's Rally of 1.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Apr 22, 4:21PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 78.01 (+0.93)
Inspire Therapy Approved for Sleep Apnea Patients at Military and VA Hospitals
PR Newswire - Wed Apr 22, 10:46AM CDT
Inspire Medical Systems, Inc., announced today that Inspire® Upper Airway Stimulation (UAS) therapy has been approved for inclusion in the Government Services Administration (GSA) Federal Supply Schedule (FSS). The agreement enables access to Inspire therapy to patients cared for at Veteran Administration hospitals, military treatment facilities, and Indian Health Services hospitals. Inspire therapy is an FDA approved implantable device for the treatment of Obstructive Sleep Apnea (OSA), a common condition affecting 18 million Americans.
MDT: 78.01 (+0.93)
North American Nerve Repair & Regeneration Market by Type, by Procedure - Forecast to 2019
M2 - Wed Apr 22, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hs9468/north_american) has announced the addition of the "North American Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) -Forecast to 2019" report to their offering. The North American nerve repair and regeneration market was valued at $1,671.4 million in 2014. It is projected to reach $2,873.0 million by 2019, at a CAGR of 11.4% during the forecast period. The market, by type, is segmented into nerve repair by neurostimulation (held largest share in 2014) and nerve repair by biomaterials. In North America, the U.S. is a key region the for nerve repair and regeneration market. Nerve repair and regeneration deals with healing damaged nerves and restoring any functioning of body parts lost due to nerve damage. This is one of the more challenging of neurological procedures. The growth of nerve repair and regeneration market has been rapid in all countries, mainly due to the constantly rising surgeries pertaining to nerves and the high incidence of chronic neurological disorders like epilepsy, Parkinson's, and Alzheimer's diseases. The increase in neurological surgeries drives the need for products such as nerve conduits, wraps, protectors, and connectors; thus, it is a driver of market growth. The North American nerve repair and regeneration market constitutes 32.8% of the global nerve repair and regeneration. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Product 6 Nerve Repair and Regeneration Market, By Country 7 Nerve Repair and Regeneration Market: Competitive Landscape 8 Nerve Repair and Regeneration Market: Company Profiles - Axogen, Inc. - Integra Lifesciences Corporation - Medtronic, Plc. - Polyganics - St. Jude Medical - Stryker For more information visit http://www.researchandmarkets.com/research/hs...h_american
MDT: 78.01 (+0.93), STJ: 73.55 (+4.43)
Medtronic DBS systems cleared for full-body MRI in Europe
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 9:38AM CDT
MDT: 78.01 (+0.93)
Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) - Forecast to 2019
M2 - Wed Apr 22, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2c5p7/asian_internal) has announced the addition of the "Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019" report to their offering. The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019 Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market. In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Asia-Pacific Internal Neuromodulation/Neurostimulation Market: Macro Indicators, By Geography, 2014 ($ Bn) 4 Executive Summary 5 Market Overview 6 Internal Neurostimulation/Neuromodulation Market, By Modality 7 Internal Neurostimulation/Neuromodulation Market, By Application 8 Internal Neurostimulation/Neuromodulation Market, By Geography 9 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape 10 Internal Neurostimulation/ Neuromodulation Market, By Company - Boston Scientific Corporation (U.S.) - Cerbomed Gmbh (Germany) - Cyberonics, Inc. (U.S.) - Depuy Synthes Companies (U.S.) - Enteromedics, Inc. (U.S.) - Medtronic, Inc. (U.S.) - St. Jude Medical (U.S.) - Synapse Biomedical, Inc. (U.S.) - Uroplasty, Inc. (U.S.) For more information visit http://www.researchandmarkets.com/research/c2...n_internal
BSX: 18.41 (+0.10), MDT: 78.01 (+0.93), STJ: 73.55 (+4.43), UPI: 1.22 (-0.03), CYBX: 63.59 (+0.27)
Health Care Equipment and Supplies Equities Technical Data - Medtronic, ResMed, Unilife, Edwards Lifesciences, and InspireMD
PR Newswire - Wed Apr 22, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
UNIS: 3.79 (-0.12), MDT: 78.01 (+0.93), RMD: 73.28 (+0.17), EW: 140.87 (+0.39), NSPR: 0.26 (+0.02)
3 Things to Know About Apple and IBM's Most Recent Cloud Computing Innovation
Andrew Tonner, The Motley Fool - Motley Fool - Tue Apr 21, 1:03PM CDT
IBM's and Apple's CEOs. Image source: IBM Beyond plenty of publicity, just what have Apple and IBM gained from the much-ballyhooed partnership they announced last July? Well, since then, Apple and IBM have introduced 23 enterprise-focused...
JNJ: 100.43 (+0.13), MDT: 78.01 (+0.93), IBM: 165.36 (+1.10), AAPL: 128.62 (+1.71)
Medtronic Begins Enrollment in Feasibility Study of Valiant 'Mona LSA' Branch Thoracic Stent Graft System
M2 - Tue Apr 21, 11:26AM CDT
Medtronic plc (NYSE: MDT) today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery (LSA).
MDT: 78.01 (+0.93)
Asian Nerve Repair & Regeneration Market by Type, by Procedure - Analysis and Forecast to 2019
M2 - Tue Apr 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/54h2rs/asian_nerve) has announced the addition of the "Asian Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Analysis and Forecast to 2019" report to their offering. The Asian nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which Nerve repair by Neurostimulation holds the highest market share of 57%, followed by nerve repair by biomaterials with a market share of 43% . The Asian Nerve repair and regeneration market is projected to grow at a CAGR of 11.7% by 2019, which is driven by several factors such as technological advancements and an increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market. In the Asian region, the maximum market share is held by Japan and China, due to the increasing diseases related to nerves such as Parkinson's and Epilepsy, as these are the major application areas for the devices , along with an increase in the population. All the same, nerve repair by neurostimulation is also widely used. The report focuses on in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas. Technological advancements have been a major driving factor of the market, which has been deeply analysed and put through the reports. Due to this increasing demand, the government has also shown its support; however, certain stringent rules and regulations such as the implementation of taxes may hamper the growth of the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Type 6 Nerve Repair and Regeneration Market, By Geography 7 Nerve Repair and Regeneration : Competitive Landscape 8 Nerve Repair and Regeneration Market, By Company - Axogen, Inc. - Integra Lifesciences Holdings Corp. - Medtronic, Inc. - Polyganics - S.T Jude Medical - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/54...sian_nerve
MDT: 78.01 (+0.93), SYK: 96.45 (+1.74)
Insulin Infusion Pumps: World Market Analysis 2015-2019
M2 - Tue Apr 21, 4:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r6qfb4/insulin_infusion) has announced the addition of the "Insulin Infusion Pumps: World Market Analysis" report to their offering. Infusion pumps are used to infuse necessary fluids, including medications and/or nutrients, to a patient's circulatory system. Insulin infusion pumps are considered specialty medical infusion pumps, ambulatory electromechanical pumps typically used to deliver insulin to patients with diabetes. They provide precise insulin delivery and lifestyle flexibility for people with diabetes by delivering small amounts of insulin continuously (24/7) to ensure normal function of the body. Insulin Infusion Pumps: World Market Analysis analyzes the current and potential world market for insulin infusion pumps, with market forecasts to 2019. The report includes discussion of: - Key Insulin Pump Products, Manufacturers, and Recent Developments - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Safety Issues - Advances in the Market The profiled companies include: - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INSULIN INFUSION PUMPS - Brief History of the Infusion Pump Industry - Diabetes Statistics, United States and Europe - Insulin Infusion Pumps - Continuous Glucose Monitoring Systems - Key Insulin Pump Products, Manufacturers, and Recent Developments - Animas Corporation - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care, Inc. - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Manufacturer Profiles - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development Co., Ltd - Tandem Diabetes Care, Inc. - Safety Issues - Advances in the Market For more information visit http://www.researchandmarkets.com/research/r6...n_infusion
JNJ: 100.43 (+0.13), PODD: 30.79 (-0.20), MDT: 78.01 (+0.93)
3 Stocks Driving The Health Care Sector Higher
at The Street - Mon Apr 20, 12:24PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
MDT: 78.01 (+0.93), UNH: 117.81 (-1.47), AMGN: 169.10 (+0.64)
IBM Employs Watson Capabilities Into Healthcare Analytics
Lior Ronen - at Seeking Alpha - Mon Apr 20, 11:25AM CDT
JNJ: 100.43 (+0.13), MCK: 231.27 (-0.02), MDT: 78.01 (+0.93), IBM: 165.36 (+1.10), AAPL: 128.62 (+1.71), CERN: 72.41 (+0.19)
Study of Upper Airway Stimulation (UAS) Therapy for Sleep Apnea Named a Top Ten Outstanding Research Paper
PR Newswire - Mon Apr 20, 11:00AM CDT
Inspire Medical Systems, Inc., announced today that a scientific paper on its Inspire Upper Airway Stimulation (UAS) therapy for obstructive sleep apnea (OSA), has been recognized with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. The awards were announced at the Forum's Annual Meeting in Washington, D.C. The 10 winning papers were chosen based on their degree of innovation from a pool of more than 50 nominations from 30 research and academic health centers nationwide.
MDT: 78.01 (+0.93)
MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks"
M2 - Mon Apr 20, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgkmfx/medintellibase) has announced the addition of the "MedIntelliBase? Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks"
" subscription to their offering. Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage. MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require. In particular, MedIntelliBase (MIB) MarketTracks are concise Summaries of Clinical Trials and Product Technologies. All Clinical Trial Summaries are indexed by Company, Principal Investigator (PI) and PI Study Site. All Product Technology Summaries are indexed by Company. The Summaries are updated throughout the month published in final form each month with Summary Update Emails sent to you and RSS Breaking News fed to you. For the Subject Area ""Lower Limb ""Critical Limb Ischemia (CLI) Therapeutics - MarketTracks: As of January 2015 the Number of Clinical Trials/Registries included = 45; the Number of Product Technologies included = 25; the Number of Companies included = 22. This Subject Area is growing as its authors discover newly announced trials and emerging product technologies. Key Topics Covered: 1. Arteries 2. Therapeutic Approach 3. Clinical Focus 4. Companies Companies Mentioned - Abbott Vascular Devices - AtheroMed, Inc. - Bard Peripheral Vascular, Inc. / C. R. Bard - BIOTRONIK - Boston Scientific Corporation, Inc. - Cardiovascular Systems, Inc. - Cook, Inc. - Covidien (eV3) - CryoVascular Systems, Inc. (Boston Scientific Corporation) - Edwards Lifesciences - EKOS Corporation - Guidant Corporation (Abbott Vascular Devices/Boston Scientific Corporation) - Intact Vascular, Inc. - Invatec (Medtronic) - Lutonix, Inc. - Medtronic (Bayer / MEDRAD Interventional (Possis Medical, Inc.)) - Medtronic Vascular - Spectranetics Corporation - TriReme Medical - Terumo Medical Corporation - Vascular Solutions, Inc. For more information visit http://www.researchandmarkets.com/research/fg...ntellibase BSX: 18.41 (+0.10), SPNC: 34.65 (-0.07), MDT: 78.01 (+0.93), CSII: 39.07 (+0.01), EW: 140.87 (+0.39), VASC: 33.30 (+4.06)
MedIntelliBase Lower Limb Advanced Arterial Therapeutics Alerts ("LLA[A] Rx Alerts"
M2 - Mon Apr 20, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/48j45j/medintellibase) has announced the addition of the "MedIntelliBase? Lower Limb Advanced Arterial Therapeutics Alerts ("LLA[A] Rx Alerts"
" subscription to their offering. MedIntelliBase? Alerts Subject Area - Lower Limb Advanced Arterial Therapeutics Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage. In particular, MedIntelliBase Alerts services instantly gives you the intelligence you need - whenever and wherever you are MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require. MedIntelliBase Alerts precisely targets clinical research abstracts and news for you - tracking, filtering, emailing, streaming, pushing via apps and archiving (keyword searchable) critical technology, regulatory and market developments using keywords you specify in your industry segment. This Subject Area is growing as its authors discover news and abstracts about newly emerging product technologies; medical advancements; new competitors; regulatory, legal and commercial activity. Key Topics Covered: 1. Arteries 2. Therapeutic Approach 3. Clinical Focus 4. General PAD Literature 5. Aachen Resonance 6. Abbott Vascular (Guidant Corporation) 7. AngioScore 8. Angioslide 9. Atrium Medical 10. Avinger 11. B. Braun Vascular 12. Bard 13. BIOTRONIK 14. Boston Scientific Corporation 15. Blue Medical 16. Cardionovum 17. Cardiovascular Systems Inc. 18. Cook Medical 19. Cordis 20. Covidien (eV3 / Fox Hollow) 21. Edwards Lifescience 22. EuroCor 23. Hansen Medical 24. Medtronic Vascular (Invatec) 25. NovoStent Corporation 26. Spectranetics 27. Terumo Medical 28. TriReme Medical 29. W. L. Gore For more information visit http://www.researchandmarkets.com/research/48...ntellibase BSX: 18.41 (+0.10), SPNC: 34.65 (-0.07), MDT: 78.01 (+0.93), CSII: 39.07 (+0.01), HNSN: 0.90 (-0.01)
Global Defibrillators Market 2015-2019 - Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)
M2 - Mon Apr 20, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4vpdf/defibrillators) has announced the addition of the "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019" report to their offering. The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Factors such as development of technologically advanced defibrillator, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillator, and increasing number of training and awareness programs across the globe are propelling the growth of the market. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In addition to this, the increasing pricing pressure on market players and frequent product recalls are the key challenges faced by market players in the market. On the basis of regions, this market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2014, North America is expected to dominate the global defibrillators market. Growth of this region can be attributed to the technological advancements and product innovations, increasing number of public defibrillation programs, rising prevalence of obesity, and rising focus of key players to expand their business in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019, due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Defibrillators Market, By Product 8 Global Defibrillators Market, By End User 9 Defibrillator Market, By Region 10 Competitive Landscape 11 Company Profiles - Biotronik Se & Co.KG - Boston Scientific Corporation - Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited) - Heartsine Technologies, Inc. - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare (A Division of Koninklijke Philips N.V.) - Physio-Control, Inc. - ST. Jude Medical, Inc. - Sorin Group - Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) For more information visit http://www.researchandmarkets.com/research/w4...brillators
BSX: 18.41 (+0.10), MDT: 78.01 (+0.93), STJ: 73.55 (+4.43)
Pain-Free Blood Tests? Sign Me Up!
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 19, 8:19AM CDT
Source: National Cancer Institute, Facebook. One of the primary tenets of the Patient Protection and Affordable Care Act, known affably as Obamacare, is to lower the uninsured rate and open avenues for consumers to get proper preventative care....
MDT: 78.01 (+0.93), EXAS: 22.28 (+0.24), MNKD: 4.90 (-0.09)
3 Megatrends in Healthcare
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 19, 6:14AM CDT
Source: AstraZeneca. For investors, the healthcare sector is where dreams can be made many times over -- or potentially lost in a flash. Although all sectors look to the horizon and think about "what might be," no sector is more reliant on the...
ANTM: 152.84 (-0.04), MYGN: 33.74 (+0.28), MDT: 78.01 (+0.93), PFE: 34.93 (+0.04), CERN: 72.41 (+0.19), NVS: 103.45 (-0.62)
